CompaniesOther
Sensydia
Private. Sensydia is committed to developing technology for the rapid, non-invasive diagnosis and management of patients with heart disease.
- Last round
- $6M Funding
- Backed by
- Colle Capital Partners
- Launched
- Not recorded
- People
- 4
Overview
Every fact carries a numbered source. Where we can't source something, it says so.
Identity fields from the company record are sourced where a source is recorded; those have no number.
- Headquarters
- Valencia, CA2
- Sector
- Not recorded
- Geography
- Valencia, CA
- Founded
- Not recorded
Funding
How much has Sensydia raised?
Rounds and backers, each sourced.
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who leads Sensydia?
Names and titles only, each sourced.
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1About | Sensydia opens in a new tabPeople · accessed Oct 13, 2026
- 2Sensydia | Faster & Safer Cardiac Assessment opens in a new tabHeadquarters, Website · accessed Oct 13, 2026
- 3